[CALL FOR ABSTRACTS!] GVIRF Vaccine and Research Innovation Meeting in Brazil

Published on October 15, 2024

The Global Vaccine and Immunization Research Forum (GVIRF) is calling for abstracts for its March 2024 event in Rio de Janeiro, Brazil. Organized by the Bill & Melinda Gates Foundation, the U.S. National Institute of Allergy and Infectious Diseases, and WHO, the forum will focus on vaccine research and innovation aligned with Immunization Agenda 2030. The deadline for submissions is November 22, 2024, and accepted participants will present posters at GVIRF 2025. Early career scientists are encouraged to apply.

For inquiries, contact: [email protected].

GVIRF 2025 Agenda Overview .pdf
GVIRF 2025 Abstract Template.docx
GVRF 2025 Call of Abstracts.pdf
Other news

WHO: Better Use of Vaccines Could Reduce Antibiotic Use by 2.5 Billion

October 15, 2024
A recent WHO report highlights that better use of vaccines could reduce global antibiotic use by 2.5 billion doses annually, addressing antimicrobial resistance (AMR). Vaccines prevent infections and reduce the misuse of antibiotics, particularly for diseases like pneumonia, typhoid, and malaria. Expanding vaccine coverage and developing new vaccines, such as those for tuberculosis and Klebsiella

Unicef: Democratic Republic of the Congo Starts Mpox Vaccination

October 15, 2024
The Democratic Republic of the Congo (DRC) has started vaccinating vulnerable groups against mpox in high-priority provinces. Supported by UNICEF, WHO, Gavi, and Africa CDC, 265,000 doses of the MVA-BN vaccine have been delivered. The vaccination campaign focuses on protecting health workers, contacts of mpox cases, and immunocompromised individuals. Mpox has heavily affected children, with over 3